Loading…
CIK 0002011932 • 8 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("exome-asset-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 10X GENOMICS INC | CL A COM | $2.7M | 1.3%Prev: 1.2% | 163,658 SH | Increased |
| ADAGENE INC | ADS | $2.0M | 1.0% | 1,060,221 SH | New |
| AGIOS PHARMACEUTICALS INC | COM | $3.7M | 1.8% | 136,942 SH | New |
| ALDEYRA THERAPEUTICS INC | CALL | $518K | 0.2% | 100,000 SH | New |
| ALUMIS INC | COM | $2.9M | 1.4%Prev: 0.7% | 292,250 SH | Increased-520 SH |
| ALUMIS INC | PUT | $519K | 0.2% | 53,200 SH | New |
| APELLIS PHARMACEUTICALS INC | COM | $3.4M | 1.6% | 135,849 SH | New |
| ARBUTUS BIOPHARMA CORP | COM | $363K | 0.2%Prev: 0.2% | 75,484 SH | Increased |
| ARROWHEAD PHARMACEUTICALS IN | COM | $3.3M | 1.6%Prev: 2.2% | 49,758 SH | Decreased-54,749 SH |
| ASTRAZENECA PLC | SPONSORED ADR | $5.3M | 2.5%Prev: 2.6% | 28,362 SH | Increased |
| BELITE BIO INC | SPONSORED ADS | $2.3M | 1.1% | 14,328 SH | New |
| BRIDGEBIO PHARMA INC | COM | $6.2M | 3.0%Prev: 4.2% | 80,723 SH | Decreased-52,364 SH |
| CELCUITY INC | COM | $3.4M | 1.6% | 34,289 SH | New |
| COGENT BIOSCIENCES INC | COM | $10.9M | 5.2%Prev: 3.9% | 305,568 SH | Increased-137,979 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $1.1M | 0.5%Prev: 1.8% | 139,543 SH | Decreased-90,419 SH |
| CYTOKINETICS INC | COM NEW | $7.9M | 3.8%Prev: 4.7% | 124,749 SH | Increased-17,668 SH |
| CYTOMX THERAPEUTICS INC | COM | $3.2M | 1.5%Prev: 1.4% | 745,305 SH | Increased |
| DEXCOM INC | COM | $3.3M | 1.6% | 50,147 SH | New |
| DISC MEDICINE INC | COM | $3.7M | 1.8%Prev: 2.5% | 46,743 SH | Decreased-14,613 SH |
| DISC MEDICINE INC | PUT | $1.3M | 0.6% | 16,000 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $2.5M | 1.2%Prev: 1.7% | 100,046 SH | Decreased-73,393 SH |
| ELEVANCE HEALTH INC FORMERLY | COM | $6.0M | 2.9% | 17,191 SH | New |
| ELI LILLY & CO | COM | $8.4M | 4.0%Prev: 3.6% | 7,852 SH | Increased |
| ENLIVEN THERAPEUTICS INC | COM | $3.4M | 1.6% | 222,308 SH | New |
| ESTABLISHMENT LABS HLDGS INC | COM | $955K | 0.5%Prev: 0.3% | 13,100 SH | Increased |
| FULCRUM THERAPEUTICS INC | COM | $1.0M | 0.5%Prev: 0.6% | 92,055 SH | Increased-6,744 SH |
| GLAUKOS CORP | COM | $3.6M | 1.7%Prev: 1.3% | 31,471 SH | Increased+4,328 SH |
| GOSSAMER BIO INC | COM | $1.4M | 0.7%Prev: 0.7% | 451,699 SH | Increased |
| GUARDANT HEALTH INC | COM | $10.0M | 4.8%Prev: 3.7% | 98,182 SH | Increased |
| IMMUNOCORE HLDGS PLC | ADS | $2.7M | 1.3% | 76,750 SH | New |
| IMMUNOVANT INC | COM | $4.0M | 1.9%Prev: 1.5% | 158,622 SH | Increased |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $1.2M | 0.6% | 600,000 SH | New |
| INTUITIVE SURGICAL INC | COM NEW | $3.6M | 1.7%Prev: 1.7% | 6,358 SH | Increased |
| IONIS PHARMACEUTICALS INC | COM | $9.2M | 4.4%Prev: 5.2% | 116,515 SH | Increased-14,501 SH |
| IQVIA HLDGS INC | COM | $1.2M | 0.6% | 5,378 SH | New |
| IRONWOOD PHARMACEUTICALS INC | COM CL A | $2.2M | 1.0% | 648,532 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $4.5M | 2.2% | 26,494 SH | New |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $2.2M | 1.0% | 295,541 SH | New |
| LIQUIDIA CORPORATION | COM NEW | $3.1M | 1.5%Prev: 1.3% | 91,148 SH | Increased-3,087 SH |
| NATERA INC | COM | $4.3M | 2.0%Prev: 1.8% | 18,650 SH | Increased |
| NEXTCURE INC | COM NEW | $2.3M | 1.1% | 165,000 SH | New |
| NOVABRIDGE BIOSCIENCES | SPONSORED ADS | $2.0M | 1.0% | 499,587 SH | New |
| PALISADE BIO INC | COM | $1.8M | 0.9% | 758,203 SH | New |
| PENUMBRA INC | COM | $2.8M | 1.3%Prev: 1.4% | 9,000 SH | Increased |
| PRAXIS PRECISION MEDICINES I | COM NEW | $17.1M | 8.2%Prev: 3.3% | 58,122 SH | Increased-43,874 SH |
| PRECIGEN INC | PUT | $418K | 0.2%Prev: 0.2% | 100,000 SH | Increased |
| RAPT THERAPEUTICS INC | COM NEW | $481K | 0.2% | 14,194 SH | New |
| SOLENO THERAPEUTICS INC | PUT | $328K | 0.2% | 7,100 SH | New |
| TENET HEALTHCARE CORP | COM NEW | $1.2M | 0.6%Prev: 2.2% | 6,084 SH | Decreased-12,016 SH |
| TRAVERE THERAPEUTICS INC | COM | $3.4M | 1.6%Prev: 2.3% | 89,052 SH | Decreased-67,865 SH |
| TRAVERE THERAPEUTICS INC | PUT | $2.9M | 1.4% | 74,700 SH | New |
| ULTRAGENYX PHARMACEUTICAL IN | PUT | $810K | 0.4% | 35,200 SH | New |
| UNITED THERAPEUTICS CORP DEL | COM | $3.7M | 1.8%Prev: 1.7% | 7,685 SH | Increased+1,040 SH |
| UNITEDHEALTH GROUP INC | COM | $1.9M | 0.9% | 5,835 SH | New |
| UNIVERSAL HLTH SVCS INC | CL B | $3.8M | 1.8%Prev: 1.0% | 17,628 SH | Increased+9,673 SH |
| UPSTREAM BIO INC | COM | $1.8M | 0.8%Prev: 0.6% | 64,845 SH | Increased+12,885 SH |
| VERA THERAPEUTICS INC | CL A | $6.3M | 3.0%Prev: 2.7% | 124,391 SH | Increased-31,681 SH |
| VERASTEM INC | COM NEW | $3.1M | 1.5% | 401,743 SH | New |
| WAVE LIFE SCIENCES LTD | SHS | $7.2M | 3.4% | 421,488 SH | New |
| WAYSTAR HLDG CORP | COM | $2.3M | 1.1%Prev: 1.1% | 68,969 SH | Increased+22,069 SH |
| 13F-HR |
| 0001420506-26-001714 |
| $162.1M |
| View |
| Aug 15, 2025 | Q2 2025 | 13F-HR/A | 0001420506-25-002212 | $134.5M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001420506-26-001033 | $193.3M | View |
| May 16, 2025 | Q1 2025 | 13F-HR/A | 0001420506-25-001316 | $112.5M | View |